CA2127457A1 - Methode de preparation et utilisations de 4,5-dihydrogeldanamycine et de son hydroquinone - Google Patents

Methode de preparation et utilisations de 4,5-dihydrogeldanamycine et de son hydroquinone

Info

Publication number
CA2127457A1
CA2127457A1 CA002127457A CA2127457A CA2127457A1 CA 2127457 A1 CA2127457 A1 CA 2127457A1 CA 002127457 A CA002127457 A CA 002127457A CA 2127457 A CA2127457 A CA 2127457A CA 2127457 A1 CA2127457 A1 CA 2127457A1
Authority
CA
Canada
Prior art keywords
compound
pharmaceutical composition
mammalian subject
formula
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002127457A
Other languages
English (en)
Inventor
Walter P. Cullen
Mark T. Jefferson
Mikel P. Moyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2127457A1 publication Critical patent/CA2127457A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA002127457A 1992-01-06 1992-12-03 Methode de preparation et utilisations de 4,5-dihydrogeldanamycine et de son hydroquinone Abandoned CA2127457A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06
US817,235 1992-01-06

Publications (1)

Publication Number Publication Date
CA2127457A1 true CA2127457A1 (fr) 1993-07-22

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002127457A Abandoned CA2127457A1 (fr) 1992-01-06 1992-12-03 Methode de preparation et utilisations de 4,5-dihydrogeldanamycine et de son hydroquinone

Country Status (15)

Country Link
JP (1) JPH06510913A (fr)
KR (1) KR940703923A (fr)
CN (1) CN1074937A (fr)
AU (1) AU3225693A (fr)
BR (1) BR9207024A (fr)
CA (1) CA2127457A1 (fr)
CZ (1) CZ390592A3 (fr)
FI (1) FI943207A7 (fr)
HU (1) HU9401936D0 (fr)
IL (1) IL104289A0 (fr)
MX (1) MX9300011A (fr)
NO (1) NO942532D0 (fr)
PT (1) PT101169A (fr)
WO (1) WO1993014215A1 (fr)
ZA (1) ZA9333B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794342B2 (ja) * 1993-06-29 1998-09-03 ファイザー・インク． 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1923061A1 (fr) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Procédé pour la préparation de 17-allyl amino geldanamycine (17-AAG) et autres ansamycines
CA2460498A1 (fr) 2001-09-24 2003-04-03 Conforma Therapeutics Corporation Procede de preparation de 17-allyl amino geldanamycine (17-aag) et d'autres ansamycines
WO2003066005A2 (fr) 2002-02-08 2003-08-14 Conforma Therapeutics Corporation Ansamycines a proprietes pharmacologiques et biologiques ameliorees
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
US7241754B2 (en) 2003-06-13 2007-07-10 Kosan Biosciences, Inc. 2-Desmethyl ansamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6870049B1 (en) 2003-11-12 2005-03-22 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
AU2004294950A1 (en) * 2003-11-26 2005-06-16 Entelos, Inc. Treatment of rheumatoid arthritis with Hypoxia-Inducible Factor 1alpha antagonists
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
AU2004309395C1 (en) 2003-12-23 2012-10-04 Infinity Discovery, Inc. Analogs of benzoquinone-containing ansamycins for the treatment of cancer
CN1898212B (zh) * 2003-12-23 2012-06-13 无限发现公司 用于治疗癌症的包含苯醌的安沙霉素类似物
AU2006230447A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
KR20090075856A (ko) * 2006-11-09 2009-07-09 바이오티카 테크놀로지 리미티드 신규한 화합물 및 이의 제조방법
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
CN100500668C (zh) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 格尔德霉素衍生物及其制备方法和制备药物的用途
EP2121957A4 (fr) 2007-01-26 2010-11-10 Kosan Biosciences Inc Macrolactames obtenus par biosynthèse modifiée
EP2297109A4 (fr) * 2008-04-21 2011-06-22 Biocon Ltd Procédé d isolement et de purification de la geldanamycine
KR20110090925A (ko) 2008-10-15 2011-08-10 인피니티 파마슈티컬스, 인코포레이티드 안사마이신 하이드로퀴논 조성물
CN102030764B (zh) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4，5双氢噻嗪酮格尔德霉素及其制备方法
CN103305563B (zh) * 2013-06-14 2014-12-03 湖南农业大学 一种以链霉菌提制阿里沙霉素的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
NO942532L (no) 1994-07-05
NO942532D0 (no) 1994-07-05
MX9300011A (es) 1993-12-01
PT101169A (pt) 1994-03-31
FI943207A0 (fi) 1994-07-05
FI943207L (fi) 1994-07-05
CN1074937A (zh) 1993-08-04
KR940703923A (ko) 1994-12-12
ZA9333B (en) 1994-07-05
BR9207024A (pt) 1995-12-05
FI943207A7 (fi) 1994-07-05
IL104289A0 (en) 1993-05-13
WO1993014215A1 (fr) 1993-07-22
CZ390592A3 (en) 1993-08-11
HU9401936D0 (en) 1994-09-28
JPH06510913A (ja) 1994-12-08
AU3225693A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
CA2127457A1 (fr) Methode de preparation et utilisations de 4,5-dihydrogeldanamycine et de son hydroquinone
CA1335083C (fr) Substance fr901228 et sa preparation
EP0132082B1 (fr) Composés antibiotiques/antitumoraux et leur production
US5015578A (en) BMY-41950 antitumor antibiotic
JPH08175990A (ja) Ｐｉ３キナーゼ阻害剤とその製造法
EP0185456B1 (fr) Composés antibiotiques/antitumoraux CL-1577D et CL-1577E, leur obtention et leur emploi
JP2863637B2 (ja) 新規なアミノオリゴ糖誘導体およびその製造方法
US4578383A (en) CL 1565 antibiotic compounds
EP0087021B1 (fr) Composés antibiotiques CL 1565 et leur préparation
US5756536A (en) Microbial transformation of taxol and cephalomannine
EP0042172B1 (fr) Composés antibiotiques, compositions pharmaceutiques les contenant et leur procédé de préparation
EP0046641B1 (fr) Antibiotiques, préparation microbiologique d'antibiotiques et un micro-organisme
US3873529A (en) Novel antibiotic ascofuranone and process for the production thereof
EP0066400A1 (fr) L'antibiotique roridine L-2 et sa préparation
EP0002589A1 (fr) Antibiotiques du groupe A-40104, leur préparation, et compositions les contenant
AU5554400A (en) New indolocarbazole alkaloids from a marine actinomycete
US6090610A (en) Macrolide compound 0406
US5087567A (en) Antitumor antibiotic BMY-42428
CA2017276C (fr) Conagenine, antibiotique antitumoral ou carcinostatique, production et utilisation
US4908316A (en) Streptomyces sp. N664-30 which produces an ionophore antibacterial agent
AU616946B2 (en) Antibacterial and antitumor agents ll-e33288epsilon-i and ll-e33288-epsilonbr, with processes and intermediates for producing said agents
US6693085B2 (en) Macrolide compound JK
JPH0639480B2 (ja) 新規マクロライド系抗生物質ｍ１１９
EP0289354A2 (fr) L'antibiotique TAN-950A, sa production et son utilisation
EP0452683A2 (fr) Substance antitumorale de streptomyces et son procédé de préparation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued